Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and Savolitinib. | JTO Clin Res Rep | 2021 | 34590028 | PubTator, text mining | PubMed |
| Histological and Somatic Mutational Profiles of Mismatch Repair Deficient Endometrial Tumours of Different Aetiologies. | Cancers (Basel) | 2021 | 34572765 | PubTator, text mining | PubMed |
| Molecular Markers and Targets in Melanoma. | Cells | 2021 | 34571969 | PubTator, text mining | PubMed |
| A highly multiplexed quantitative phosphosite assay for biology and preclinical studies. | Mol Syst Biol | 2021 | 34569154 | PubTator, text mining | PubMed |
| Imposing Phase II and Phase III Clinical Trials of Targeted Drugs for Glioblastoma: Current Status and Progress. | Front Oncol | 2021 | 34568049 | PubTator, text mining | PubMed |
| Oh, the Mutations You'll Acquire! A Systematic Overview of Cutaneous Squamous Cell Carcinoma. | Cell Physiol Biochem | 2021 | 34553848 | PubTator, text mining | PubMed |
| Computational Analysis of Cholangiocarcinoma Phosphoproteomes Identifies Patient-Specific Drug Targets. | Cancer Res | 2021 | 34551960 | PubTator, text mining | PubMed |
| Understanding Metabolic Remodeling in Mycobacterium smegmatis to Overcome Energy Exigency and Reductive Stress Under Energy-Compromised State. | Front Microbiol | 2021 | 34539614 | PubTator, text mining | PubMed |
| Kidney toxicity of the BRAF-kinase inhibitor vemurafenib is driven by off-target ferrochelatase inhibition. | Kidney Int | 2021 | 34534550 | PubTator, text mining | PubMed |
| Genomic alteration profiles of lung cancer and their relationship to clinical features and prognosis value using individualized genetic testing. | J Thorac Dis | 2021 | 34527339 | PubTator, text mining | PubMed |
| Integrative pan-cancer analysis of MEK1 aberrations and the potential clinical implications. | Sci Rep | 2021 | 34526571 | PubTator, text mining | PubMed |
| Deconvolution of multiplexed transcriptional responses to wood smoke particles defines rapid aryl hydrocarbon receptor signaling dynamics. | J Biol Chem | 2021 | 34520756 | PubTator, text mining | PubMed |
| A novel liquid biopsy (NETest) identifies paragangliomas and pheochromocytomas with high accuracy. | Endocr Relat Cancer | 2021 | 34515661 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| Novel insights into the pathogenesis and treatment of NRAS mutant melanoma. | Expert Rev Precis Med Drug Dev | 2021 | 34485698 | PubTator, text mining | PubMed |
| Rosai-Dorfman disease presenting with solitary liver mass without lymphadenopathy: A case report. | Clin Case Rep | 2021 | 34466261 | PubTator, text mining | PubMed |
| Ras isoform-specific expression, chromatin accessibility, and signaling. | Biophys Rev | 2021 | 34466166 | PubTator, text mining | PubMed |
| Clinical and prognostic characteristics of 95 cases of Langerhans cell histiocytosis in children: a single-institute experience from 2013 to 2020. | Ann Med | 2021 | 34459688 | PubTator, text mining | PubMed |
| Molecular profiling and identification of prognostic factors in Chinese patients with small bowel adenocarcinoma. | Cancer Sci | 2021 | 34449929 | PubTator, text mining | PubMed |
| Disruption of RING and PHD Domains of TRIM28 Evokes Differentiation in Human iPSCs. | Cells | 2021 | 34440702 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=34